Recent Finacing
Recent Raise
FoldRx is a Cambridge developer of small-molecule therapeutics targeting protein misfolding in amyloidosis, advancing tafamidis for ATTR-PN and ATTR-CM, with Parkinson's and cystic fibrosis programs on proprietary yeast-based platform.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors